Key Points
- Insider Robert (Rob) Graham Naylor sold 1,639 NIOX Group shares on October 27 at an average price of GBX 80, for £1,311.20.
- Other reported insider sales included Ian Johnson’s sale of 193,361 shares and Jonathan Emms’s sales totaling 135,396 shares; the article says multiple insider sales could weigh on investor sentiment, but gives no reasons for the transactions.
- NIOX reported quarterly EPS of GBX 1.41, with a 14.74% net margin and 10.01% return on equity. The stock opened at GBX 64.60, with a 12-month trading range of GBX 53.84–80.
NIOX Group Plc (LON:NIOX - Get Free Report) insider Robert (Rob) Graham Naylor sold 1,639 shares of the stock in a transaction that occurred on Tuesday, October 27th. The shares were sold at an average price of GBX 80, for a total value of £1,311.20.
NIOX Group Stock Up 0.3%
NIOX stock opened at GBX 64.60 on Thursday. NIOX Group Plc has a twelve month low of GBX 53.84 and a twelve month high of GBX 80. The company has a current ratio of 4.60, a quick ratio of 1.94 and a debt-to-equity ratio of 1.06. The company has a market capitalization of £271.88 million, a P/E ratio of 39.63 and a beta of 0.92. The firm has a 50 day simple moving average of GBX 67.30 and a 200-day simple moving average of GBX 63.10.
NIOX Group (LON:NIOX - Get Free Report) last issued its quarterly earnings results on Wednesday, September 30th. The company reported GBX 1.41 earnings per share (EPS) for the quarter. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%. On average, equities research analysts predict that NIOX Group Plc will post 1.17 earnings per share for the current fiscal year.
Key Headlines Impacting NIOX Group
Here are the key news stories impacting NIOX Group this week:
- Negative Sentiment: Several insiders sold shares, including Ian Johnson, who sold 193,361 shares on November 2, and Jonathan Emms, who reported two sales totalling 135,396 shares on October 27. Multiple insider sales may weigh on investor sentiment, although the reports do not state the sellers’ reasons. NIOX Group insider transactions
NIOX Group Company Profile
(
Get Free Report)
NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.
Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
